Counterfeit diagnostics

By Madhukar Pai Moderator | 13 Jun, 2018

Please see this blog post and attached article on this issue which does not get much attention (as compared to counterfeit medicines).

URL: https://www.ibm.com/blogs/research/2018/06/ink-spots-end-counterfeit-diagnost...

Replies

 

Daniel Apollos Replied at 2:01 PM, 13 Jun 2018

KoDaniel Apollos

Teri Roberts Replied at 5:28 AM, 14 Jun 2018

Hi All

Many thanks for this. I would just like to point out that the description "counterfeit" is not longer relevant since the WHO updated their definition as "The old “substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC)” terminology surfaced from the lack of a global common understanding, sometimes confusing the phenomenon of substandard and falsified products with the protection of intellectual property rights."

Thus we should also be consistent in what we mean by counterfeit diagnostics consistent with this WHO definition.

Please see here: http://www.who.int/medicines/regulation/ssffc/definitions/en/

best wishes
Teri
--
Teri ROBERTS

Diagnostics Advisor for fever & AMR | MSF Access Campaign

office: ‭+41 22 849 87 27

Skype: teri.roberts | twitter.com/#!/DxTeri

Reza Rasti Replied at 9:02 AM, 14 Jun 2018

Thanks for this post (and for a great course in Montréal this week)!

The issue with falsified diagnostic assays needs to be taken serious. These "assays" not only lead to wrongful clinical decision making, what's worse is that they create a distrust amongst health providers (and probably also patients) in real assays and their results. Something we bumped into when discussing POC tests with health care workers in Mbarara, Uganda:

/Reza Rasti
Karolinska Institutet

Attached resources: